BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2011
View Archived Issues
AMG-386 does not improve efficacy of CX combination in gastroesophageal adenocarcinoma
Read More
BI-2536 shows potential in models of osteosarcoma
Read More
Escitalopram is safe and reduces menopausal hot flashes
Read More
Phase I trial assesses temsirolimus/sorafenib combination in HCC
Read More
Genome analyses identify distinct loci for CAD and for myocardial infarction in CAD
Read More
Kyowa Hakko Kirin and Amgen collaborate on AMG-827
Read More
FDA refuses to file Gilead's Truvada/TMC-278 NDA for HIV-1
Read More
Serum level of angiogenin-directed IgM antibodies as a biomarker of response to osteosarcoma therapy
Read More
New sodium channel blockers presented
Read More
New protein kinase inhibitors described by sanofi-aventis
Read More
New inhibitors of serine/threonine-protein kinase mTOR claimed
Read More
ASSERT trial data suggest potential of RVX-208 in Alzheimer's disease
Read More
FDA clears clinical testing of AREVA's alpha radioimmunotherapy involving 212Pb
Read More
ChemoCentryx begins phase I trial of CCX-832 under alliance with GSK
Read More
Sunshine Biopharma and Binghamton University sign agreement for Adva-27a
Read More
New inhibitors discovered of PI3K-alpha/mTOR/TNF-alpha/IL-6
Read More
NIH funds AndroScience's development of AR degradation enhancer for SBMA
Read More
E.U. orphan drug status recommended for ALN-TTR01 in familial amyloidotic polyneuropathy
Read More
Enrollment begins in phase IIb RX-10100 trial in major depressive disorder
Read More
Chugai Pharma files for new indication of Pegasys
Read More
MBL-HCV1 enters phase II trial to prevent HCV reinfection in liver transplant recipients
Read More
GSK receives FDA complete response letter regarding Avodart sNDA
Read More
Anadys begins dosing in phase IIb ANA-598 trial in hepatitis C
Read More
AB Science initiates phase III masitinib study in severe asthma
Read More
Ligand Pharma acquires CyDex Pharmaceuticals
Read More